These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26690908)

  • 1. Drug-induced Parkinsonism versus Idiopathic Parkinson Disease: Utility of Nigrosome 1 with 3-T Imaging.
    Sung YH; Noh Y; Lee J; Kim EY
    Radiology; 2016 Jun; 279(3):849-58. PubMed ID: 26690908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nigrosome 1 Detection at 3T MRI for the Diagnosis of Early-Stage Idiopathic Parkinson Disease: Assessment of Diagnostic Accuracy and Agreement on Imaging Asymmetry and Clinical Laterality.
    Noh Y; Sung YH; Lee J; Kim EY
    AJNR Am J Neuroradiol; 2015 Nov; 36(11):2010-6. PubMed ID: 26294646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of 3D FLAIR and Dopamine Transporter Imaging in Patients With Parkinsonism.
    Oh SW; Shin NY; Lee JJ; Lee SK; Lee PH; Lim SM; Kim JW
    AJR Am J Roentgenol; 2016 Nov; 207(5):1089-1094. PubMed ID: 27489952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric MR imaging of Parkinsonisms at 3 tesla: Its role in the differentiation of idiopathic Parkinson's disease versus atypical Parkinsonian disorders.
    Calloni SF; Conte G; Sbaraini S; Cilia R; Contarino VE; Avignone S; Sacilotto G; Pezzoli G; Triulzi FM; Scola E
    Eur J Radiol; 2018 Dec; 109():95-100. PubMed ID: 30527319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial diagnostic workup of parkinsonism: Dopamine transporter positron emission tomography versus susceptibility map-weighted imaging at 3T.
    Sung YH; Lee J; Nam Y; Shin HG; Noh Y; Hwang KH; Lee H; Kim EY
    Parkinsonism Relat Disord; 2019 May; 62():171-178. PubMed ID: 30580909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective multi-centre study of susceptibility map-weighted MRI for the diagnosis of neurodegenerative parkinsonism.
    Sung YH; Kim JS; Yoo SW; Shin NY; Nam Y; Ahn TB; Yoo D; Lee KM; Kim HG; Koh SB; Kim J; Kim I; Kwon DY; Lee Y; Kim C; Chung SJ; Jo S; Lee SH; Kim SJ; Kim M; Lyoo CH; Baek MS; Kang SY; Chang SK; Jo SW; Lee SA; Ma HI; Kim YE; Kim ES; Kim YJ; Kim HS; Woo MH; Choi HJ; Kim EY
    Eur Radiol; 2022 May; 32(5):3597-3608. PubMed ID: 35064313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical application of nigrosome 1 detection on high-resolution susceptibility-weighted imaging in the evaluation of suspected Parkinsonism: The real-world performance and pitfalls.
    Lee J; Lee AL; Park JH; Moon JE; Park JM; Kim SJ; Chang KH
    PLoS One; 2020; 15(4):e0231010. PubMed ID: 32240236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism.
    Lee H; Sung YH; Hwang KH
    Curr Med Imaging; 2023; 19(9):1041-1051. PubMed ID: 36734891
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Yang HJ; Park SH; Seo M; Weon YC; Kim Y
    Neurotoxicology; 2018 Jan; 64():78-84. PubMed ID: 28259768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential involvement of nigral subregions in idiopathic parkinson's disease.
    Sung YH; Lee J; Nam Y; Shin HG; Noh Y; Shin DH; Kim EY
    Hum Brain Mapp; 2018 Jan; 39(1):542-553. PubMed ID: 29064601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.
    Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE
    Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI).
    Nam Y; Gho SM; Kim DH; Kim EY; Lee J
    J Magn Reson Imaging; 2017 Aug; 46(2):528-536. PubMed ID: 27859983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of ¹²³I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): a 2-year follow-up study.
    Kim JS; Oh YS; Kim YI; Yang DW; Chung YA; You IeR; Lee KS
    Arch Gerontol Geriatr; 2013; 56(1):124-8. PubMed ID: 22633343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease.
    Cheng Z; He N; Huang P; Li Y; Tang R; Sethi SK; Ghassaban K; Yerramsetty KK; Palutla VK; Chen S; Yan F; Haacke EM
    Neuroimage Clin; 2020; 25():102103. PubMed ID: 31869769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of the swallow tail sign in patients with parkinsonism and gait disorders.
    Kim DS; Tung GA; Akbar U; Friedman JH
    J Neurol Sci; 2021 Sep; 428():117581. PubMed ID: 34333378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated assessment of the substantia nigra on susceptibility map-weighted imaging using deep convolutional neural networks for diagnosis of Idiopathic Parkinson's disease.
    Shin DH; Heo H; Song S; Shin NY; Nam Y; Yoo SW; Kim JS; Yoon JH; Lee SH; Sung YH; Kim EY
    Parkinsonism Relat Disord; 2021 Apr; 85():84-90. PubMed ID: 33761389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Substantia Nigra Hyperintensity at 3.0-T MR Imaging in Idiopathic REM Sleep Behavior Disorder: Comparison with
    Bae YJ; Kim JM; Kim KJ; Kim E; Park HS; Kang SY; Yoon IY; Lee JY; Jeon B; Kim SE
    Radiology; 2018 Apr; 287(1):285-293. PubMed ID: 29232183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FP-CIT SPECT in clinically inconclusive Parkinsonian syndrome during amiodarone treatment: a study with follow-up.
    Hambÿe AS; Vervaet A; Dethy S
    Nucl Med Commun; 2010 Jun; 31(6):583-9. PubMed ID: 20429096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Imaging of Nigrosome-1 on 3T MRI and Its Comparison with 18F-DOPA PET in the Diagnosis of Idiopathic Parkinson Disease and Atypical Parkinsonism.
    Kathuria H; Mehta S; Ahuja CK; Chakravarty K; Ray S; Mittal BR; Singh P; Lal V
    Mov Disord Clin Pract; 2021 Feb; 8(2):224-230. PubMed ID: 33553492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.